Clinical trials
Fistula trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 7 |
| Unknown status | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anthony Lembo | 3 |
| Medtronic Endovascular | 2 |
| Proteon Therapeutics | 2 |
| Thomas Jefferson University | 2 |
| VentureMed Group Inc. | 2 |
| Wake Forest University Health Sciences | 2 |
| Abbott | 1 |
| Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University | 1 |
| AdventHealth | 1 |
| American Access Care | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fistula | 43 |
| Arteriovenous Fistula | 11 |
| Crohn Disease | 7 |
| Renal Insufficiency, Chronic | 4 |
| Kidney Failure, Chronic | 3 |
| Abscess | 2 |
| Esophageal Achalasia | 2 |
| Gastroesophageal Reflux | 2 |
| Inflammatory Bowel Diseases | 2 |
| Kidney Diseases | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.